IL-35 Regulates the Function of Immune Cells in Tumor Microenvironment.

Frontiers in Immunology
Kewei LiuKe Jiang

Abstract

Interleukin-35 (IL-35) is a heterodimeric cytokine composed of Epstein-Barr virus-induced gene 3 (EBI3) and IL-12p35 that has recently been shown to play diverse and important roles in the tumor microenvironment (TME). Owing to its immunosuppressive activity and ability to promote tumor growth and progression, IL-35 is widely recognized as a key mediator of TME status. Immune cells are key mediators of diverse tumor-related phenotypes, and immunosuppressive cytokines such as IL-35 can promote tumor growth and metastasis in TME. These influences should be considered together. Since tumor immunotherapy based on immune checkpoint blockade remains ineffective in many patients due to tumoral resistance, a new target or efficacy enhancing factor is urgently needed. Suppressing IL-35 production and activity has been demonstrated as an effective factor that inhibits tumor cells viability, and further investigation of this cytokine is warranted. However, the mechanistic basis for IL-35-mediated regulation of immune cells in the TME remains to be fully clarified. In the present review, we explore the roles of IL-35 in regulating immune cells within the TME. In addition, we highlight IL-35 as a specific immunological target and discuss it...Continue Reading

References

Mar 13, 2001·Annual Review of Immunology·K W MooreA O'Garra
Nov 23, 2007·Nature·Lauren W CollisonDario A A Vignali
Dec 2, 2009·European Journal of Immunology·Maria SeyerlJohannes Stöckl
Mar 9, 2010·Investigative Ophthalmology & Visual Science·Gregory M FrankRobert L Hendricks
Oct 19, 2010·Nature Immunology·Lauren W CollisonDario A A Vignali
Feb 7, 2012·Nature Immunology·Lauren W CollisonDario A A Vignali
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Jan 25, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Zhihui WangXue-Feng Bai
Feb 5, 2013·Cancer Letters·Maria Letizia TaddeiPaola Chiarugi
Mar 31, 2015·European Journal of Immunology·Karen O DixonCees van Kooten
Apr 23, 2015·Immunity·Elizabeth C Rosser, Claudia Mauri
Dec 31, 2015·Cancer Discovery·Yuliya Pylayeva-GuptaDafna Bar-Sagi
Feb 14, 2016·Immunity·Meghan E TurnisDario A A Vignali
Mar 29, 2016·European Journal of Immunology·Xiaoqian WangRenxi Wang
Apr 23, 2017·Oncotarget·Jiu-Ming ZouZuo-Hua Feng
Jun 15, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ni JiangH Kim Lyerly
Aug 16, 2017·Scientific Reports·Keun Ah RyuAaron P Esser-Kahn
Oct 6, 2017·Oncotarget·Xianqiang LiuHuan Shi
Oct 31, 2017·Frontiers in Immunology·Eva M Palsson-McDermottLuke A O'Neill
Dec 1, 2017·International Journal of Molecular Sciences·Qingshui WangHang Fai Kwok
Mar 15, 2018·Frontiers in Immunology·Hitoshi Hasegawa, Takuya Matsumoto
Mar 27, 2018·International Journal of Cancer. Journal International Du Cancer·Manouchehr TeymouriAmirhosein Sahebkar
May 10, 2018·Medicine·Ke WangJiansheng Li
Jul 11, 2018·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Hong-Min WangLin-Lin Guo
Aug 29, 2018·Frontiers in Immunology·Alex M AbelSubramaniam Malarkannan
Sep 6, 2018·International Journal of Cancer. Journal International Du Cancer·Min LiuXiubao Ren
Sep 10, 2018·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Xianglan LiuBo Yu
Oct 5, 2018·JAMA : the Journal of the American Medical Association·Douglas B JohnsonJeffrey A Sosman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.